CMA: Ontario Lists Ozempic as Limited Use; Alberta Requires Step Therapy

A Canadian Medical Association consumer explainer details how provincial coverage of semaglutide products varies sharply across Canada, with Ontario listing Ozempic as a Limited Use drug and Alberta treating it as a step therapy/special authorization drug, even as Health Canada has now cleared two generic versions [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada].

How provinces currently handle Ozempic

The CMA explainer states that GLP-1 drugs are usually covered for type 2 diabetes but that coverage rules vary by province or territory [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada]. In Ontario, the Ontario Drug Benefit Program lists Ozempic as a Limited Use drug, meaning a doctor must confirm it meets specific medical rules [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada]. In Alberta, the Alberta Drug Benefit List treats Ozempic as a step therapy/special authorization drug, and patients usually need to try other treatments first [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada].

The CMA adds that both programs cover Ozempic only for certain populations, such as seniors, and that public drug plans generally do not cover GLP-1 drugs approved for chronic weight management [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada]. Only a small number of private insurance plans offer partial coverage for GLP-1 drugs approved for chronic weight management, according to the CMA [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada].

Generic approvals reshape the substitution question

Health Canada authorized the first generic semaglutide injection, filed by Dr. Reddy's Laboratories, on April 28, 2026, making Canada the first G7 country to approve a generic version of semaglutide [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]. On May 1, 2026, Health Canada authorized a second generic semaglutide injection, filed by Canadian-based Apotex, with seven other submissions still under review [Source: canada.ca/en/health-canada/news/2026/05/canada-approves-second-generic-semaglutide-the-first-g7-country-to-do-so.html].

The CMA notes that a patient will still need a prescription for a generic drug, that a prescriber can allow the pharmacy to switch a patient to a generic, and that if insurance already approved Ozempic, it will usually cover the generic automatically once available [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada]. Patients who choose to stay on the brand-name drug instead of the generic will, in most plans, be asked to pay the price difference out of pocket [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada]. Our insurance coverage checker tracks plan-by-plan rules as generics roll out.

Cost backdrop

CBC News reported that a monthly supply of Ozempic or Wegovy costs between $300 and $400, sometimes more depending on the dose [Source: cbc.ca/news/health/ozempic-generic-health-canada-9.7180566]. Current pharmacy listings on GLP1Prices.ca show Ozempic ranging from $222 to $663 CAD across 149 samples, and Wegovy from $270 to $490 CAD across 172 samples, so the CBC figure sits within the lower portion of the live market range.

Health Canada has stated that many generic medications are 45 to 90 per cent cheaper than brand-name versions [Source: cbc.ca/news/health/ozempic-generic-health-canada-9.7180566]. University of Toronto associate professor Mina Tadrous told CBC that with three generics on the market, the price could drop to about $100 or less, depending on dose [Source: cbc.ca/news/health/ozempic-generic-health-canada-9.7180566].

What the CMA flags for patients

• Novo Nordisk's regulatory exclusivity for semaglutide ended on January 4, 2026, in Canada [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada].
• As of late December 2025, Health Canada had nine active applications from companies seeking to sell generic semaglutide [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada].
• GLP-1 drugs are prescription-only, and a website offering them without a prescription is a major red flag [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada].
• Diabetes Canada has warned about a surge in misleading online ads using fake logos and false endorsements [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada].

Health Canada said it expects to make regulatory decisions on more semaglutide submissions in the coming weeks and months [Source: canada.ca/en/health-canada/news/2026/05/canada-approves-second-generic-semaglutide-the-first-g7-country-to-do-so.html]. Readers comparing options can also review our Mounjaro, Zepbound and Rybelsus pages, our generic semaglutide tracker, and our FAQ.

This article is for informational purposes only and does not constitute medical advice.